BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Registrant: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Reported lobbying issue
Budget/Appropriations: H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues pertaining to NIH & FDA funding. Health Issues: S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 4612, the SCREEN for T1D Act; H.R. 5467 - the Patient Access to Autoimmune Treatments Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to Special Diabetes Program.
Government entities reported: HOUSE OF REPRESENTATIVES SENATE
Reported filing-period amount: $220,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.